All posts by imreal

Mindray North America Brings Operating Room to Life at American Society of Anesthesiologists 2019 Annual Meeting


Mindray North America

Mindray North America

Spanning anesthesia delivery, patient monitoring and ultrasound imaging, Mindray empowers healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools.

Mindray, a global developer of technologies and solutions for patient monitoring, anesthesia and ultrasound, invites attendees of the American Society of Anesthesiologists 2019 Annual Meeting to visit exhibit #841 and discover the operating room showcase. The exhibition takes place on October 19-21 in Orlando, Florida, and will provide more than 14,000 healthcare professionals from around the world the opportunity to interact with the latest perioperative solutions. Technologies highlighted in the exhibit include:

Patient Monitoring & Life Support

  • A7 Advantage Anesthesia Delivery System: Designed to complement clinical workflow and enhance patient care, this System expands on other anesthesia platforms. By offering electronic fresh gas technology to ensure precise flow dynamics and deliver low flow anesthesia, the A7 System enables clinicians to reduce OR operating costs by decreasing the amount of inhalation agent used.
  • BeneVision N-Series Patient Monitoring Platform: Modular, comprehensive and efficient, this suite of patient monitors supports clinical excellence. In tandem with the BeneVision Distributed Monitoring System, this platform enables clinicians to observe, manage and document a patient’s condition in support of high-quality, patient-centric care from admission to discharge. Options such as cardiopulmonary bypass (CPB) mode, NMT, rSO2, anesthetic gas module and OR-specific user configurations make this a preferred solution for both anesthesiologists and surgical staff.
  • BeneVision Distributed Monitoring System (DMS): Combined with the A7 System, this comprehensive suite of perioperative solutions not only showcases anesthesia delivery and ventilation, but also emphasizes complementary patient monitoring and seamless interoperability solutions which support a complete patient record throughout the care path.


Ultrasound

  • TE7 Ultrasound System Crystal Series: With best-in-class image quality, a sleek form factor and an intuitive touchscreen, the TE7 System is designed to provide superior performance for rapid, confident exams and procedures in the fast-paced, point-of-care environment. This System also features numerous needle visualization advancements, including eSpacial Navi™, a 4D magnetic needle navigation technology that delivers enhanced needle visualization and location during procedures.


“In accordance with our mission to change lives by making the most advanced healthcare technology attainable for all, we continue our long-standing commitment to the perioperative care environment with disruptive and game-changing solutions,” said Mindray North America President Wayne Quinn. “Spanning anesthesia delivery, patient monitoring and ultrasound imaging, Mindray empowers healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools.”

Team members will be onsite throughout the duration of the exhibit, providing demonstrations and addressing questions from attendees. Visit Mindray at exhibit #841 to learn more about these innovative and cutting-edge solutions, ideally suited for use across the entire perioperative space.

About Mindray

Mindray is a leading developer, manufacturer and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.

Share article on social media or email:

Midstate Radiology Associates, LLC Announces the Acquisition of Vein Centers of Connecticut


Midstate Radiology Associates, LLC

Midstate Radiology Associates, LLC

Bringing together these two companies will make it easier for patients to access cutting edge treatment of vein disease throughout Connecticut.

Founded in 1955, Midstate Radiology Associates has been a leader in diagnostic and therapeutic radiology for over 60 years. With more than 40 board certified radiologists and over 15 imaging locations throughout Connecticut, Midstate is affiliated with The Hospital of Central Connecticut, Midstate Medical Center, Backus Hospital and the Hospital for Special Care, among others. Midstate offers comprehensive imaging services, including low-dose digital X-ray, 3T MRI, CT scans, ultrasounds and 3D mammograms, as well as cutting-edge interventional procedures that place patient comfort and safety first.

The radiologists and staff at Vein Centers of Connecticut have been treating patients with varicose veins and venous reflux disease since 2004. Using the newest technologies, including laser ablation, radiofrequency ablation and VenaSeal closure, they have performed over 8,000 ablation procedures. With compassion, it is their mission to help patients look their best and feel their best.

The radiologists at Vein Centers of CT have many affiliations, which include the American College of Radiology, the American Board of Phlebology and the Society of Interventional Radiology. With locations in New Britain, Madison and Wallingford, the Vein Centers of CT are recognized for their professionalism and friendly, personalized care.

“We are extremely pleased to bring Vein Centers of Connecticut’s talented physicians and staff to a larger patient base through this acquisition. Bringing together these two companies will make it easier for patients to access cutting edge treatment of vein disease throughout Connecticut,” said Tom Cappas MBA, MS RT (R)(MR) Director of Operations for Midstate Radiology Associates, LLC.

Share article on social media or email:

Allstate Insurance Company Files $1.6 Million Healthcare Fraud Lawsuit Against Four Pharmacies, Five Professional Medical Corporations, and their Owners


Without the support of lawmakers, incidents of fraud will continue to increase. We need to work together this legislative session to fix the broken no-fault system.

Allstate Insurance Company is seeking to recover more than $1.6 million from 19 New York area defendants. Since 2003, Allstate has filed 88 fraud lawsuits in New York State seeking more than $330 million in damages.

The complaint was filed in the United States District Court for the Eastern District of New York against the following defendants: New Century Pharmacy, Inc., Refill Rx Pharmacy, Inc., My Rx Pharmacy, Inc., Direct Rx Pharmacy, Inc., Eduard Aronov, Katrin Matatov, Alexander Sharafyan, Boris Kandov, Rafo Yaguda f/k/a Rafail Yagudayev, Mani Ushyarov, D.O., Amr A. El-Sanduby, M.D., Jean-Pierre Georges Barakat, M.D., Tomas M. Pattugalan, Jr., M.D., Rafael Antonio Delacruz-Gomez, M.D., First Class Medical, P.C., NY Medical Arts, P.C., Richmond Medical Care, P.C., GONY Medical Services, P.C., and Life Health Care Medical, P.C.

Allstate alleges that New Century Pharmacy, Inc., Refill Rx Pharmacy, Inc., My Rx Pharmacy, Inc., and Direct Rx Pharmacy, Inc., and their owners, Eduard Aronov, Katrin Matatov, Alexander Sharafyan, Boris Kandov, and Rafo Yaguda f/k/a Rafail Yagudayev, took advantage of New York’s No-Fault laws by producing and dispensing compounded topical pain medications and other drugs in violation of New York law. Allstate also alleges that First Class Medical, P.C., NY Medical Arts, P.C., Richmond Medical Care, P.C., GONY Medical Services, P.C., and Life Health Care Medical, P.C., and their owners, Mani Ushyarov, D.O., Amr A. El-Sanduby, M.D., Jean-Pierre Georges Barakat, M.D., Tomas M. Pattugalan, Jr., M.D., and Rafael Antonio Delacruz-Gomez, M.D. violated New York law by prescribing medically unnecessary medications, and by fraudulently providing and billing for evaluations and tests that were medically unnecessary, falsely charged, and not provided in the manner represented. Allstate further alleges that the pharmacies and the medical providers conspired together during the course of this scheme to prescribe, produce, dispense, and deliver compounded topical pain medications and other drugs that were medically unnecessary, not uniquely tailored to each patient’s needs, and falsely charged.

According to the Insurance Information Institute, no-fault fraud is costing New Yorkers millions of dollars year-after-year. “In essence, honest hardworking New Yorkers are paying a “fraud tax,” said Christina Kelly, Allstate New York spokesperson. “We need lawmakers to enact meaningful insurance reform that puts the citizens of New York first.”

Allstate is joined by other insurers and many New York State leaders in its pursuit for comprehensive reform of the no-fault system. “The no-fault system is being exploited and responsible citizens are the victims,” Kelly said. “Without the support of lawmakers, incidents of fraud will continue to increase. We need to work together this legislative session to fix the broken no-fault system.”

Case Number: 1:19-cv-5702

Share article on social media or email:

Blockchain Logistics Platform dexFreight Appoints Jim Handoush President and CEO


https://www.prweb.com/

Jim Handoush brings to dexFreight a strong track record in technology, transportation and logistics industries

I look forward to bringing dexFreight’s vision to supply chain stakeholders and to having a positive impact on transportation and logistics operations in markets around the globe

dexFreight, providers of a decentralized, blockchain-based logistics platform, today announced that Jim Handoush will serve as its President and CEO. In his new role, Handoush will focus on strengthening and expanding the use of dexFreight’s technology.

“dexFreight is shrinking the gap between shippers, carriers and brokers by continually developing its blockchain solution and tools that reduce costs, improve productivity and increase revenue and profitability,” Handoush said. “I look forward to bringing dexFreight’s vision to supply chain stakeholders and to having a positive impact on transportation and logistics operations in markets around the globe.”

Jim Handoush brings to dexFreight a strong track record in technology, transportation and logistics industries building high-performance teams and leading complex organizations with Fortune 500 customers. Previously, he served as the Executive Vice President of Transportation and Logistics Solutions at Optym, a global software development leader that provides optimization solutions to transportation companies; and held multiple executive roles in Landstar System, Inc, a worldwide, asset-light provider of integrated transportation management solutions.

With the appointment of Jim Handoush as President and CEO, dexFreight CEO and co-founder Rajat Rajbhandari will assume the role of Chief Information Officer and focus on market research and fostering relationships with governmental and academic institutions.

“When we founded dexFreight in early 2018, we understood its enormous potential and knew that we would need leaders with a deep background in scaling and running multi-billion dollar companies,” Rajbhandari said. “As our technology continues to mature, the timing is perfect for someone like Jim Handoush to step in and take the helm. His keen interest in innovation and deep experience will drive our growth in the coming years.”

About dexFreight

dexFreight is a decentralized, blockchain-based logistics platform that allows shippers, carriers and other supply chain stakeholders to transact and collaborate more efficiently, transparently and securely. For information, visit http://www.dexfreight.io.

Share article on social media or email:

New launch from AristaMD increases wound care and dermatology consult support by facilitating seamless eConsult image transfer


News Image

AristaMD, an innovative telehealth platform that delivers primary care providers timely and documented specialist insight, announced today the launch of an app allowing its providers to easily transfer images as part of the eConsult platform. The new web-based AristaMD Photo App is an easy-to-access, streamlined, and HIPAA-compliant solution that further enhances electronic consultation efficiency and effectiveness for cases needing visual references—most commonly the dermatology consult.

AristaMD, which launched in 2013, aims to improve healthcare outcomes by connecting its thousands of participating payers and providers to specialists through eConsults. It is already proven to deliver cost-effective, more timely access to specialty care. Providers simply use their mobile phone to take photos through the app, which are automatically and securely saved exclusively to the AristaMD platform, then continue to process their referral order and eConsult as usual.

There are fewer practicing dermatologists in rural regions. Geographic barriers compound the issue of long wait times for specialist appointments. According to a recent report,“since 2009 patient wait times for a dermatology appointment have increased by 46 percent, or from an average of 22.1 days to 32.3 days in 2017.” Timely access to care for dermatological issues can have a significant impact on patient health, as conditions include life-threatening and quickly progressing conditions such as skin cancer. Researchers have found “providing specialty treatment to a potential melanoma within 14 days of diagnosis could improve a patient’s prognosis by 20 percent.”

Use of AristaMD’s eConsults have proven highly effective with 81 percent of dermatology consults replacing a face-to-face visit with a dermatologist. The Photo App will continue improving patient access to this specialty care for even more case uses.

“Currently, patients are waiting anywhere from two to four months for a specialist appointment, but the reality is that a large portion of those specialist referrals are not needed,” said Brooke LeVasseur, CEO of AristaMD. “The new AristaMD Photo App will help PCPs continue to significantly reduce unnecessary face-to-face referrals in even more cases needing visual documentation. This marks one of many product innovations my team has been working on to expand the benefits of eConsults to as many patients as possible.”

For additional information on AristaMD’s Photo App, please visit: https://www.aristamd.com/resources/literature/aristamd-photo-app-brochure/

About AristaMD

eConsult Solutions That Improve Quality of Care

AristaMD is focused on improving patient outcomes through more timely access to specialty care. Its eConsult platform provides a telehealth solution that empowers primary care providers with clinical workup checklists and the ability to conduct electronic consults (also known as eConsults or virtual consults) to significantly improve the patient referral process and allow greater access to timely, high-quality care. Designed to seamlessly integrate into physician referral workflows, the platform allows payers and providers to quickly and cost-effectively launch specialist eConsults using their own specialists or those provided by AristaMD’s board-certified panel of experts. AristaMD’s platform has proven to deliver cost-effective, timely access to specialty care through eConsults, significantly reducing the need for face-to-face visits while increasing patient satisfaction. Committed to driving better health outcomes, AristaMD partners with healthcare stakeholders to ensure their success in the transition to value-based care.

For additional information, visit: http://www.aristamd.com, or follow AristaMD on LinkedIn and Twitter.

Share article on social media or email:



The Dominguez Firm is Pleased to Announce Two Additional Academic Scholarships for 2019


The Dominguez Firm, LLP

The Dominguez Firm, LLP

The Dominguez Firm, a California based personal injury firm continues its commitment to education by offering two additional scholarships for deserving students in 2019. The firm had previously recognized two outstanding students with scholarships earlier in the year. Undergraduate and law school students who demonstrate excellence both in the classroom and their communities are encouraged to apply for the firm’s Collegiate Scholarship and Legal Scholarship Awards.

Juan Dominguez, founder of The Dominguez Firm established the Collegiate and Legal Scholarship Awards to help worthy students achieve their dreams. Seeing education as a right, not a privilege, Mr. Dominguez has always held the belief that finances should never get in the way of a hard-working student interested in pursuing a college education or becoming a lawyer.

Details of the two scholarships being offered:

The Dominguez Firm Collegiate Scholarship Award – is for recent high school graduates or first year undergraduate students who are or will be enrolled in an accredited university. This award will be presented to an undergraduate student who consistently displays academic excellence while looking to effect positive change in their community. The recipient will be awarded a $5,000 scholarship towards their college tuition.

The Dominguez Firm Legal Scholarship Award – was established for students who are or will be enrolled in an accredited law school. The award will go to a worthy student who has been accepted into or is currently enrolled in law school. Recognizing the substantial effort involved in studying law, students who find the time to help others in spite of their schedules should be recognized and applauded. The firm will award the winner a scholarship for $2,500.

The deadline to apply is December 31, 2019. Winners will be announced in early 2020.

Official rules and guidelines can be found at: https://dominguezfirm.com/scholarships/.

We wish everyone the best of luck!

The Dominguez Firm is a nationally recognized personal injury, workers’ compensation and employment law firm that has been successfully meeting the needs of our clients for over 30 years. For a free and confidential case consultation, please call us at 1-800-818-1818.

Share article on social media or email:

Carole Robbins’s newly released “Ginny the Giraffe” is a short yet delightful children’s tale about a child exploring the dynamics of family relationships.


News Image

“Ginny the Giraffe”: a charming illustrated book that follows Ginny the Giraffe as she discovers that there’s more to life than fun and games while also realizing what she loves and who she treasures. “Ginny the Giraffe” is the creation of published author Carole Robbins, a retired Air Force nurse who lives in rural western North Carolina with her family and pets. She loves to read, sew, travel, but, most of all, loves God and country.

Robbins shares, “Ginny the Giraffe is about a child exploring family relationships. Ginny has fun but also experiences difficulty with her brother and family dynamics. Ginny realizes life has challenges, but in the end she realizes what is important to her.”

Published by Christian Faith Publishing, Carole Robbins’s new book is a lovely story for kids and their parents that ignites fun and enjoyment as Ginny learns the beauty of family relationships.

View a synopsis of “Ginny the Giraffe” on YouTube.

Consumers can purchase “Ginny the Giraffe” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Ginny the Giraffe,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

MacXDVD Software Rolls Out Support for macOS Catalina on All Media Solutions


News Image

MacXDVD Software, the leading multimedia software developer, today announces a significant upgrade of its flagship MacX DVD Ripper Pro and MacX Video Converter Pro with support for macOS Catalina. This upgrade means that Mac users are able to convert 4K/HD videos and rip any DVD discs while enjoying the benefits of macOS Catalina.

The latest macOS Catalina makes a great next step for Mac with automatic dark mode, redesigned apps, and improved Find My Mac feature etc, definitely being a worthy upgrade for Mac. But few programs in the industry own the full support of Catalina, and even some still adopt 32-bit apps, which will stop working with macOS Catalina. To keep up the pace with the new macOS and introduce a focus on 64-bit apps, MacXDVD includes macOS Catalina in support of its leading video converter and DVD ripper.

The upgraded MacX DVD Ripper Pro V6.2.4 allows macOS Catalina users to rip and backup any DVDs to MP4, MOV, AVCHD, MKV, iPhone 11/Pro/Max, 2019 iPad Pro, Apple TV, 4K TV, Samsung, Huawei within 5 minutes. One-click to digitize the overstocked DVD discs, regardless of 99-title DVDs, TV series discs, latest-released movies, homemade discs, etc. to personal movie library on Mac or portable devices.

MacX Video Converter Pro V6.4.4 continues high-quality 4K/HD video conversion on macOS 10.15. It transcodes videos in AVI, VP9, HEVC, AVCHD (mts/m2ts), MKV, MP4, VVC and compresses large-sized HD/4K videos to 40%-90% smaller for Apple TV, VLC player, YouTube, iPhone, iPad, Android or other devices and platforms.

Besides the macOS Catalina support, MacXDVD also makes some other enhancements for its DVD ripping software and video converter, for example, adding new output profiles for iPhone 11, 11 Pro/Max, new 10.2-inch iPad and new Apple TV for both, fixing the occasional sound error when converting a few DVD, improving online helper to support the latest video and music and fixing some minor bugs.

Pricing and Availability

MacX DVD Ripper Pro and MacX Video Converter Pro are normally priced $59.95 and $45.95 respectively for a single license copy per year. To celebrate the new Apple releases, the upgraded MacX Media Management Suite, f.t. the upgraded 4K video converter, DVD ripper, and iPhone manager, media player, is 70% off at $49.95 only, totally for savings of $120. Check more details & discounts at https://www.macxdvd.com/special-offer/

About MacXDVD Software, Inc.

MacXDVD Software is a multimedia software developer dedicated to providing a range of trusted and innovative products across Mac, Windows, iOS, Android, including MacX Video Converter, MacX DVD Ripper, MacX MediaTrans, DVD Author, DVD backup tools, etc, series of apps for Apple video player, iPad iPhone manager, and iOS-based 2D and 3D video games.

Share article on social media or email:

Roland DGA Expands Award-Winning TrueVIS Wide-Format Printer/Cutter Lineup with New Value-Packed SG2 Series


Roland's new SG2 series wide-format printer/cutters make next-generation TrueVIS performance and reliability extremely affordable.

Roland’s new SG2 series printer/cutters offer advanced TrueVIS imaging capabilities, integrated contour cutting, and exceptional value.

“Our SG2 series delivers all the color, performance and reliability that new and growing print service providers need to build their businesses at an exceptional price.” – Daniel Valade, Roland DGA Product Manager, Color Products and Cutters

Roland DGA Corporation, a leading provider of wide-format printers, printer/cutters and other advanced digital imaging devices, has announced the addition of new SG2 series printer/cutters to its second-generation TrueVIS™ series. Available in 64-inch, 54-inch and 30-inch models, the SG2 series offers many of the innovative features and capabilities of Roland’s award-winning TrueVIS VG2 inkjets at extremely attractive pricing. In addition, the SG2 printer/cutters with TR2 ink have earned print durability warranty program certifications from the industry’s top media manufacturers, including the 3M MCS Warranty and Avery Dennison’s ICS Performance Guarantee.

Like all Roland TrueVIS series printer/cutters, the new SG2-640, SG2-540 and SG2-300 are designed to provide unsurpassed image quality, versatility, productivity and ease of use for wide-format graphics providers. With its two FlexFire™ print heads, new TR2 eco-solvent inks in a CMYK configuration, and low operating costs, the SG2 makes TrueVIS performance and reliability more affordable than ever.

To take full advantage of its superior color reproduction capability and the wide color gamut provided by Roland’s specially formulated TR2 ink, the SG2 includes a new True Rich Color preset. Now, vibrant color can be combined with neutral grays, smooth gradations and natural skin tones to create stunning graphics. The SG2 series’ outstanding print capabilities and accurate integrated cutting make these value-packed inkjets unbeatable for a wide range of applications ranging from signs, banners, displays, and die-cut labels/decals to window graphics, vehicle wraps, heat transfer apparel, and interior décor.    

“Our SG2 series delivers all the color, performance and reliability that new and growing print service providers need to build their businesses at an exceptional price,” said Daniel Valade, Roland DGA Product Manager, Color Products and Cutters. “These efficient, extremely versatile inkjets give those just entering the sign and graphics market the capabilities they need to succeed, while allowing existing shops to expand their product offerings and maximize profitability.”

The SG2’s myriad technical improvements include a new automatic pinch roller systems requiring minimal operator intervention, a Multiple Print function that allows for highly accurate automated printing and cutting without requiring the use of crop marks, and a precision PerfCut function for producing high quality die-cut ready-made labels/decals without the need for trimming. A new optional take-up unit that supports two modes according to the type of media being used and increases take-up stability for smooth post- processing further enhances performance and value.

To ensure optimum image quality, the SG2 printer/cutter’s FlexFire print heads incorporate new waveform technology to control the precise firing of TR2 ink droplets. Simultaneous control of variable droplets results in unparalleled image quality, print after print. In addition, the SG2 is equipped with innovative features that minimize running costs and increase profitability, including a newly developed ink delivery system that automates maintenance sequences to reduce ink consumption by up to 54 percent.*

All TrueVIS SG2 models come with Roland’s VersaWorks® 6 RIP software – the company’s most powerful RIP to date. VersaWorks 6 boasts the latest Harlequin® dual core engine with PDF 2.0 and native 64-bit processing, a new icon-based interface with drag-and-drop functionality, and a host of additional tools that optimize printer functionality and ease of use.

To learn more about Roland’s new TrueVIS SG2 series wide-format printer/cutters, visit https://www.rolanddga.com/SG2. For more information on the complete Roland DGA product line, visit https://www.rolanddga.com.

*In comparison with the previous SG series using TR inks.

About Roland DGA Corporation

Roland DGA Corporation serves North and South America as the marketing, sales, distribution and service arm for Roland DG Corporation. Founded in 1981 and listed on the Tokyo Stock Exchange, Roland DG of Hamamatsu, Japan is a worldwide leader in wide-format inkjet printers for the sign, apparel, textile, personalization and vehicle graphics markets; engravers for awards, giftware and ADA signage; photo impact printers for direct part marking; and 3D printers and CNC milling machines for the dental CAD/CAM, rapid prototyping, part manufacturing and medical industries. For more information, visit https://www.rolanddga.com.

About Roland DG Corporation

Roland DG Corporation is the world’s leading provider of digital printing solutions. The company’s inkjet printers, printer/cutters and cutting machines are widely used to create a broad range of promotional items including banners, signs, vehicle graphics, stickers and labels, and to provide customization services for apparel and personal items like smartphone cases. Recently, Roland DG has embarked on a promising new retail frontier by capitalizing on individuals’ increasing desire to create their own, uniquely designed and decorated items. The company’s COTO business division has developed proprietary design and print management software which enables customers to design their own gifts, apparel and treasured mementos, and to enjoy an unforgettable creative experience. For more information, visit https://www.rolanddg.com/en.

Share article on social media or email:

Former CEO of MetroPlus Health Plan, Dr. Arnold Saperstein, Joins Cecelia Health as Chief Medical Officer


https://www.prweb.com/

Dr. Arnold Saperstein named CMO of Cecelia Health

Cecelia Health, a leading technology-enabled chronic disease management company based in New York City, has hired former President and CEO of MetroPlus Health Plan, Arnold Saperstein MD, FACP, as Chief Medical Officer. Saperstein began his career in managed care in 1992 and joined MetroPlus Health Plan in 1995 initially as Chief Medical Officer and then as President and CEO from 2006 until 2019. MetroPlus Health Plan, a wholly-owned subsidiary of the New York City Health + Hospitals is a managed care organization that, under Saperstein’s leadership grew from 40,000 members to over 500,000 members with an estimated 32,000 participating providers.

“I am excited and energized to join Cecelia Health to help advance the important work they’re doing to transform lives and outcomes. Providing access to high quality care regardless of geography is a top priority for Cecelia Health. I’m looking forward to launching and managing our virtual diabetes and mental health specialty clinic to enhance the level of care we can provide to the people we serve,” said Saperstein.

Saperstein has spent the majority of his career developing programs that ensure the highest quality of care. During his tenure at MetroPlus, it ranked as one of the highest scoring plans for quality of care as measured by the New York State Department of Health Medicaid Incentive Program and by the Medicaid Consumer Guide for New York City. Under his leadership, MetroPlus rose to the forefront of Value Based Purchasing. Programs he developed included groundbreaking quality incentive pay for performance programs across the entire MetroPlus network.

Dr. Saperstein will play a key role in expanding the services that Cecelia Health delivers to its customers across the pharmaceutical, medical device and health plan market segments. These services include the national rollout of diabetes and related mental health tele-medicine and innovative digital health solutions.

“We are thrilled to welcome Dr. Saperstein to the Cecelia Health team,” says David Weingard, CEO of Cecelia Health. “His extensive experience in population health and management of large networks in a managed care environment will significantly advance our ability to innovate and positively transform the lives and health outcomes of the people we serve.”

About Cecelia Health

Cecelia Health’s mission is to positively transform the lives of people living with chronic diseases. Cecelia Health’s expert clinicians use Cecelia Health’s proprietary technology-enabled personalized coaching solution to optimize health outcomes at a low cost per patient and provide unique data-driven insights to health plans and ACOs seeking to improve quality measures, and pharmaceutical and medical device companies seeking to improve adherence. Cecelia Health has also engaged in numerous joint initiatives with the Juvenile Diabetes Research Foundation, American Diabetes Association, the Diabetes Research Institute, the American Association of Diabetes Educators, the Jaeb Center for Health Research and the Helmsley Charitable Trust.

Share article on social media or email: